205 related articles for article (PubMed ID: 17291753)
1. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
[TBL] [Abstract][Full Text] [Related]
2. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
[TBL] [Abstract][Full Text] [Related]
3. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
[TBL] [Abstract][Full Text] [Related]
5. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
7. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585
[TBL] [Abstract][Full Text] [Related]
8. Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model.
Gagné-Boulet M; Fortin S; Lacroix J; Lefebvre CA; Côté MF; C-Gaudreault R
Eur J Med Chem; 2015 Jul; 100():34-43. PubMed ID: 26069928
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
Kaffy J; Pontikis R; Florent JC; Monneret C
Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
[TBL] [Abstract][Full Text] [Related]
10. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
11. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
12. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
13. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
[TBL] [Abstract][Full Text] [Related]
14. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
15. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
[TBL] [Abstract][Full Text] [Related]
16. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
17. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas.
Fortin S; Moreau E; Lacroix J; Côté MF; Petitclerc E; C-Gaudreault R
Eur J Med Chem; 2010 Jul; 45(7):2928-37. PubMed ID: 20400211
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
Pinna GA; Murineddu G; Murruzzu C; Zuco V; Zunino F; Cappelletti G; Artali R; Cignarella G; Solano L; Villa S
ChemMedChem; 2009 Jun; 4(6):998-1009. PubMed ID: 19291736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
